Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 01, 2024 at 03:00 am
Share
Dr. Lal PathLabs Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 5,389 million compared to INR 4,894 million a year ago. Revenue was INR 5,572 million compared to INR 4,999 million a year ago. Net income was INR 813 million compared to INR 528 million a year ago. Basic earnings per share from continuing operations was INR 9.77 compared to INR 6.37 a year ago. Diluted earnings per share from continuing operations was INR 9.76 compared to INR 6.35 a year ago.
For the nine months, sales was INR 16,812 million compared to INR 15,259 million a year ago. Revenue was INR 17,320 million compared to INR 15,534 million a year ago. Net income was INR 2,732 million compared to INR 1,822 million a year ago. Basic earnings per share from continuing operations was INR 32.88 compared to INR 22 a year ago. Diluted earnings per share from continuing operations was INR 32.81 compared to INR 21.92 a year ago.
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.